시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 경기력 향상 약물 시장 보고서(2025년)
Performance Enhancing Drugs Global Market Report 2025
상품코드 : 1769706
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,278,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,075,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,872,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

경기력 향상 약물 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 활력을 높이고 노화를 방지하는 제품에 대한 투자 증가, 피로 및 만성 스트레스와 관련된 조건의 급증, 신흥 시장에서의 채택 확대, 유전자 도핑 및 합성 생물학의 활용 증가 등이 있습니다. 교육 및 직업 환경에서 인지 향상에 대한 관심이 증가하고 있습니다. 향후 예상되는 현저한 동향으로서는 의약품 제제의 혁신, 신약에 있어서의 AI 활용, 하이테크를 구사한 개별화 서플리먼트, 유전자 편집과 합성 생물학의 비약적 발전, 향지성 화합물 개발의 계속적인 발전이 있습니다.

피트니스 활동에 대한 관심 증가는 미래의 경기력 향상 약물 시장의 성장을 가속할 것으로 예측됩니다. 활동에 대한 관심이 높아지고 있는 것은 주로 건강 의식의 고조에 의한 것으로, 만성 질환의 예방이나 전체적인 건강의 유지에 있어서의 신체 운동의 중요성을 인식하는 개인이 증가하고 있기 때문입니다. 이를 통해 근육 성장을 가속하고 피로를 완화하고 보다 길고 격렬한 훈련 세션을 가능하게 하여 피트니스 활동으로 더 큰 성과를 올릴 수 있도록 지원합니다. 2024년 11월에 발표한 보고서에 따르면 2024년에는 개인의 48%가 정기적인 운동을 하고 있으며, 이는 전년보다 3% 증가한 수치입니다.

스포츠 참가의 급증은 향후 경기력 향상 약물 시장의 성장을 가속할 것으로 예측됩니다. 운동은 심장혈관의 건강을 개선하고 정신적 행복을 높이고 만성 질환의 위험을 줄이는 것을 더 많은 사람들이 알고 있기 때문에 신체 활동의 건강상의 이점에 대한 인식 증가로 인한 것입니다. 어떤 신체적 특성을 향상시키고 운동선수가 보다 집중적으로 훈련하고, 피로를 경감하며, 신체적 제약을 극복하고, 경기 중에 최고의 퍼포먼스를 유지할 수 있게 함으로써, 스포츠 참가를 지원합니다. Sports & Fitness Industry Association(SFIA)에 따르면 2023년 팀스포츠 참가자는 전년 대비 약 800만명 증가했으며 2022년 대비 11%의 성장을 보였습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Performance-enhancing drugs are substances designed to boost physical or mental performance by enhancing strength, endurance, focus, or recovery. These substances are frequently used with the intent of improving athletic output, accelerating progress, and achieving better results from training. Their usage is often linked to a strong ambition for excellence and success in competitive environments.

The primary types of performance-enhancing drugs include stimulants, anabolic steroids, peptide hormones, beta-2 agonists, and others. Stimulants work by activating the central nervous system, resulting in heightened alertness, increased energy levels, and improved physical capabilities. These substances are used in a range of scenarios, such as by athletes, students, military personnel, among others, and are distributed via various channels like online platforms, pharmacies, specialty outlets, gyms, and direct sales. The target end users include professional and amateur athletes, bodybuilders, fitness enthusiasts, and patients with chronic health conditions.

The performance enhancing drugs market research report is one of a series of new reports from The Business Research Company that provides performance enhancing drugs market statistics, including performance enhancing drugs industry global market size, regional shares, competitors with the performance enhancing drugs market share, performance enhancing drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the performance enhancing drugs industry. This performance enhancing drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The performance enhancing drugs market size has grown strongly in recent years. It will grow from $10.79 billion in 2024 to $11.42 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. Growth during the historic period was driven by increased enthusiasm for competitive sports, a heightened focus on body image and physical appearance, broader online accessibility to PEDs, historical use in military and defense contexts, and a rise in off-label usage across general populations.

The performance enhancing drugs market size is expected to see strong growth in the next few years. It will grow to $14.16 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. Key drivers in the forecast period include rising investment in products that enhance vitality and combat aging, a surge in conditions linked to fatigue and chronic stress, expanding adoption in emerging markets, increased utilization of gene doping and synthetic biology, and growing interest in cognitive enhancement within educational and professional environments. Prominent trends anticipated include innovations in pharmaceutical drug formulations, the use of AI in drug discovery, tech-driven personalized supplements, breakthroughs in gene editing and synthetic biology, and continued progress in nootropic compound development.

The rising interest in fitness activities is expected to propel the growth of the performance enhancing drugs market going forward. Fitness activities refer to physical exercises or movements performed to improve or maintain one's health, strength, flexibility, or overall physical condition. The increasing interest in fitness activities is primarily driven by greater health awareness, as more individuals recognize the importance of physical exercise in preventing chronic diseases and maintaining overall well-being. Performance enhancing drugs improve physical capabilities such as strength, endurance, and recovery, thereby supporting individuals in achieving greater results in fitness activities by accelerating muscle growth, reducing fatigue, and enabling longer and more intense training sessions. For instance, in November 2024, according to the report published by PureGym, a UK-based health company, in 2024, 48% of individuals are taking part in regular exercise, which is a 3% increase from the previous year. Therefore, the growing interest in fitness activities is driving the growth of the performance enhancing drugs market.

The surge in sports participation is expected to propel the growth of the performance enhancing drugs market going forward. Sports participation refers to the act of taking part in organized or informal physical activities or games, either individually or as part of a team. This increase in sports participation is primarily due to rising awareness of the health benefits of physical activity, as more people recognize that regular exercise can improve cardiovascular health, boost mental well-being, and reduce the risk of chronic diseases. Performance enhancing drugs aid in sports participation by improving physical attributes such as strength, endurance, speed, and recovery time, allowing athletes to train more intensively, reduce fatigue, overcome physical limitations, and maintain peak performance during competitive events. For instance, in October 2024, according to the Sports & Fitness Industry Association, a US-based non-profit organization, SFIA data indicated that participation in team sports increased by about 8 million people in 2023 compared to the previous year, marking an 11% growth from 2022. Therefore, the increase in sports participation is fueling the growth of the performance enhancing drugs market.

Major companies operating in the performance enhancing drugs market are focusing on developing solutions such as nootropic supplements aimed at enhancing cognitive functions such as memory, focus, and mental clarity. Nootropic supplements refer to substances-natural, synthetic, or a combination-designed to enhance cognitive functions including memory, learning, attention, focus, and mental clarity. For instance, in February 2022, Jones Soda, a US-based beverage company, launched a nootropic supplement beverage formulated to support focus, mental clarity, and brain health. The product is inspired by Mike Tyson's personal journey of healing brain injury and emotional trauma through natural, fungal, and plant-based remedies. The beverage contains a proprietary blend of nootropics and adaptogens, including L-theanine, N-acetyl tyrosine, lion's mane mushroom extract, and essential B vitamins (B3, B5, B6, and B12), along with a small amount of caffeine. This formulation is intended to deliver a clean energy boost and cognitive support without the typical mushroom-based taste. The drink is available in two flavors, Tyson's Punch and Tiger's Blood, both offering fruity, crisp, and flavorful profiles in line with Jones Soda's reputation for craft beverages.

Major players in the performance enhancing drugs market are Pfizer Inc., Bayer AG, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Organon & Co, Douglas Laboratories, Balkan Pharmaceuticals, Onnit Labs LLC, Geneza Pharmaceuticals, Taj Pharmaceuticals, British Dragon, Aspen API, Zhengzhou Pharmaceutical Co., Hilma Biocare, and Sciroxx.

North America was the largest region in the performance enhancing drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in performance enhancing drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the performance enhancing drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The performance enhancing drugs market consists of sales of clear float performance-enhancing drugs, steroid precursors (prohormones), human growth hormone (hGH), erythropoietin (EPO), and creatine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Performance Enhancing Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on performance enhancing drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for performance enhancing drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The performance enhancing drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Performance Enhancing Drugs Market Characteristics

3. Performance Enhancing Drugs Market Trends And Strategies

4. Performance Enhancing Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Performance Enhancing Drugs Growth Analysis And Strategic Analysis Framework

6. Performance Enhancing Drugs Market Segmentation

7. Performance Enhancing Drugs Market Regional And Country Analysis

8. Asia-Pacific Performance Enhancing Drugs Market

9. China Performance Enhancing Drugs Market

10. India Performance Enhancing Drugs Market

11. Japan Performance Enhancing Drugs Market

12. Australia Performance Enhancing Drugs Market

13. Indonesia Performance Enhancing Drugs Market

14. South Korea Performance Enhancing Drugs Market

15. Western Europe Performance Enhancing Drugs Market

16. UK Performance Enhancing Drugs Market

17. Germany Performance Enhancing Drugs Market

18. France Performance Enhancing Drugs Market

19. Italy Performance Enhancing Drugs Market

20. Spain Performance Enhancing Drugs Market

21. Eastern Europe Performance Enhancing Drugs Market

22. Russia Performance Enhancing Drugs Market

23. North America Performance Enhancing Drugs Market

24. USA Performance Enhancing Drugs Market

25. Canada Performance Enhancing Drugs Market

26. South America Performance Enhancing Drugs Market

27. Brazil Performance Enhancing Drugs Market

28. Middle East Performance Enhancing Drugs Market

29. Africa Performance Enhancing Drugs Market

30. Performance Enhancing Drugs Market Competitive Landscape And Company Profiles

31. Performance Enhancing Drugs Market Other Major And Innovative Companies

32. Global Performance Enhancing Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Performance Enhancing Drugs Market

34. Recent Developments In The Performance Enhancing Drugs Market

35. Performance Enhancing Drugs Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기